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Background: Currently, Saphenous vein (SV) and internal thoracic artery (ITA) are still the most common graft materials
in Coronary Artery Bypass Grafting (CABG) whereas SV graft have a lower long-term patency than ITA. Vascular smooth
muscle cells (VSMCs) phenotype conversion, proliferation and migration may play a key role in mechanism of vein graft
restenosis. To explore differential gene expression profile in VSMCs from SV and ITA will help to further elucidate the
mechanism of VSMCs in vein graft restenosis after CABG and to provide new thread of gene therapy.
Methods: VSMCs from paired SV and ITA were cultured for experiments of Affymetrix microarrays and verification using
FQ RT-PCR, while the database for annotation, visualization and integrated discovery bioinformatics resources (DAVID 2.0)
was utilized for bioinformatics analysis of differential gene expression profile between SV VSMCs and ITA VSMCs. RNA of
tunica media from SV and ITA segments were extracted for FQ RT-PCR to display differential expression of PLAT.
Results: 54,613 probe sets were examined by gene microarray experiments. In SV VSMCs, 1,075 genes were up-regulated
and 406 of them were higher than two-fold; 1,399 genes were down-regulated and 424 of them were lower than two-
fold as compare with ITA VSMCs.14 ECM-related genes differentially expressed were verificated and listed as following:
COL4A4, COL11A1, FN1, TNC, THBS, FBLN, MMP3, MMP9, TIMP3, WNT5A, SGCD were higher whereas COL14A1, ELN, PLAT
lower in SV VSMCs than ITA VSMCs. In addition, PLAT was lower in tunica media from SV segments than ITA.
Conclusion: VSMCs from SV and ITA have distinct phenotypes characteristics. Both promoting and inhibiting migration
ECM-related genes were higher in VSMCs from SV as compared with ITA, suggesting that VSMCs from SV have more
potential migrating capability whereas less PLAT both in SV VSMCs and vascular tissue,implying that SV may prone to be
restenosis after CABG.
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Coronary artery bypass grafting (CABG) is one of most
effective treatment of coronary heart disease, especially
applied in severe patients with multivessel disease and
multiple risk factors. Saphenous vein (SV) and internal
thoracic artery (ITA) are routinely used grafts in CABG.
However, SV grafts exhibit lower patentcy and higher
patient mortality as compare with ITA grafts; up to 50%* Correspondence: binlancn@163.com
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reproduction in any medium, provided the orof the SV grafts occlude within 10 years after implan-
tation but rarely of ITA grafts [1]. The difference is
probably related to the vascular properties, leading to
accelerated atherosclerosis of SV grafts after CABG,
whereas resistance of ITA grafts [2].
Restenosis of SV grafts is featured by early thrombosis,
intimal thickening in metaphase, and final accele-
rated atherosclerosis [3]. Vascular smooth muscle cells
(VSMCs) phenotype conversion, proliferation and mi-
gration play a significant role in the complex patho-
logical process and influence the long-term patency of
venous grafts [4]. VSMCs consist of heterogeneous. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vascular developmental stages. VSMCs from veins and
arteries have different embryonic origins and exhibit dif-
ferent intrinsic characteristic [5]. Hence, VSMCs from
SV and ITA may have distinct intrinsic properties as well,
thereby determining patency rates of grafted vessels.
The process VSMCs migration from tunica media to
the intima accompanied with extracellular matrix (ECM)
remodeling is a dynamic balance of matrix synthesis and
degradation [6]. ECM play an important role in the
process of VSMCs migration and restenosis. ECM is
degraded to form tunnel to facilitate VSMCs migration
from tunica media to intima. In addition, ECM compo-
nents interaction and associated signal transduction
participated in restenosis process such as VSMCs pheno-
type conversion, proliferation and migration. Once ECM
secretion and degradation lose the balance, VSMCs
proliferaion and migration may be promoted subse-
quently result in restenosis.
Tissue-type plasminogen activator (PLAT/t-PA) is a
significant serine protease associated with ECM degrad-
ation and mediates the conversion of plasminogen to
plasmin [7]. As the main ingredient of fibrinolytic sys-
tem, PLAT plays an important role in prevention and
treatment of restenosis so that has been widely used in
clinical [8]. The endothelium is indeed a rich source of
PLAT; loss of the endothelial layer renders fibrinolysis
dependent on PLAT released from VSMCs [9]. Defi-
ciency of PLAT may lead to grafts thrombosis and re-
stenosis after CABG.
VSMCs from SV and ITA possess different intrinsic
properties and exhibit distinct response to stimuli.
VSMCs from SV are more differentiated and show
higher contractility whereas prone to proliferation and
migration compared to cells from ITA. [3,9,10] The spe-
cific mechanisms are still unclear so that comparing dif-
ferential gene expression profile of VSMCs from SV and
ITA will help to further understanding the molecular
mechanisms of grafts restenosis after CABG and en-
lighten new ideas of treatment.
Methods
Vessels gathering and VSMCs culture This study was
approved by Clinical Research Ethics Committee of
Affiliated Shantou Hospital of Sun Yat-sen University
(2009005). SV and ITA tissue were obtained from 21 pa-
tients undergoing coronary artery bypass grafting in
Guangdong General Hospital and immediately preserved
in −80°C refrigerators. SV and ITA VSMCs were isolated
by explant-culture method from fresh specimens. The
identity of each VSMCs isolate was confirmed by im-
munofluorescent staining for SMα-actin (DAKO Cor-
poration). VSMCs of passage 2 ~ 8 endured 48 h serum
deprivation were prepared for subsequent experiments.Cell proliferation assays were taken using MTT kit
(keyGEN). VSMCs were divided into 3 groups with
differental factors: serum-free DMEM/F12, DMEM/F12
containing 10% FBS or DMEM/F12 containing 10 ng/ml
PDGF-BB, and were observed immediately and cultured
after 48 h, 96 h, 144 h. Three separate experiments each
with 3 replicate wells for each condition were performed
for the assays.
RNA isolation
Total RNA of confluent VSMCs were isolated using
TRIZOL reagent (Invitrogen) and the quality was
detected by UV Bio-Photometer (Eppendorf ). Only sam-
ple with a 260/280 nm ratio between 1.9 and 2.1 as well
as a 28S/18S ratio between 1.5 and 2.0 were included for
further experiments.
−70°C preserved vessels specimen were dislodged
standing at room temperature. After adventitia removed
and intima scrapped, the remaining tunica media of
vessels were rinsing and extracted by grinding in liquid
nitrogen. Total RNA of the tissue was isolated and
assessed as the same as VSMCs.
Microarray gene expression profiling and bioinformatics
analysis
VSMCs cultured from 3 paired vessels originated from
the same patients were selected for the gene microarray
experiments. Total RNA was isolated as described and
reverse-transcribed using Affymetrix one-cycle cDNA
Synthesis Kit, then the cDNA was transcribed to biotin-
labeled cRNA using GeneChip IVT Labeling Kit. Biotin-
labeled cRNA was fragmented for hybridization to
GeneChip Human Genome U133 Plus 2.0 arrays. After
16 h of hybridization, arrays were washed and stained
using Genechip fluidics station 450 then scan using
gene array scanner 3000. All the process were strictly
according to Affymetrix GeneChip Operations Manual.
The raw data was gathered by Affymetrix GCOS 1.4
software (Affymetrix, Santa Clara, CA) with MAS 5.0 al-
gorithm standardization. Fold changes of gene expression
difference >2.0 were list for subsequent bioinformatics
analysis using DAVID 2.0 (the database for annotation,
visualization and integrated discovery bioinformatics
resources), including the GO (gene ontology), PA (path-
ways, including KEGG, BIOCARTA database) analysis.
The index of the DAVID and literature Huang da W
described on Nature Protocols were consulted for analy-
tical methods, and relative recommending values were
deployed for the main parameters settings [11].
Fluorescent quantitation real time polymerase chain
reaction
After bioinformatics analysis, 14 ECM-related genes
differential expression were verified by fluorescent
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RT-PCR). cDNA was synthesized using Reverse Tran-
scription System Kit (Promega) and identified by PCR
and agarose gel electrophoresis. Only cDNA exhibiting
amplification strap consistent with target gene as well
as non primer dimmer was selected for subsequent
amplication of 14 ECM-related genes mRNA. The for-
ward and reverse primer (Table 1) synthesized by
TAKARA were applied for FQ RT-PCR. The same con-
dition was used for all candidate genes as following: 1 μl
of templete cDNA, 5 μl l 2 × PCR Master Mix, 0.2 μl pri-
mer F (10 μmol/L), 0.2 μl primer P (10 μmol/L), 3.6 μl
RNase-free water by using the following cycling parame-
ters: 95° for 15 seconds for 1 cycle, 95° for 5 seconds,
60° for 15 seconds, 72° for 20 seconds, for a total of
40 cycles. 3 parallel holes were set up for each gene. TheTable 1 PCR primer of 14 ECM-related gene













































β-actin/R GATAGCAACGTACATGGCTGGGdata was standardized using β-actin as reference gene
for further analysis. 12 paired VSMCs from SV and ITA
were taken for the consolidation experiments. 21 SV and
13 ITA segments, including 12 paired samples, were ap-
plied for detetion of PLAT.
Statistics
For disparate experiment, VSMCs from same or different
patients were used. Accordingly, statistical evaluation
was performed by paired or independent nonparameter
test: Wilcoxon Signed Ranks Test or Mann–Whitney
Test as appropriate. A P-value < 0.05 was considered sta-
tistically significant.
Results
Cell identification and cell proliferation assay
VSMCs were cultured (Figure 1) and identified by im-
munofluorescence using DAPI labeled nuclei and TRITC
marked SMα-actin in the cytoplasm. The cells > 95% pur-
ity were selected for subsequent experiments (Figure 2).
VSMCs cultured in medium with different factors
displayed distinct cell growth curve (Figure 3). Both
VSMCs from SV and ITA exhibited intense responsibil-
ity to FBS and PDGF-BB with dramatic proliferation
reacting to stimuli.(Figure 4) In SV VSMCs, the data
detected after 96 h and 144 h between PDGF-BB and
DMEM/F12 was statistically significant. (P < 0.05 or
P < 0.01). In ITA VSMCs, the data detected after 48 h,
96 h and 144 h between PDGF-BB and DMEM/F12 was
statistically significant. (P < 0.01).
Microarray gene expression profiling and bioinformatics
analysis
54,613 probe sets were examined by gene microarray ex-
periments and the differential gene expression profile of
VSMCs from SV and ITA was processed for further bio-
informatics analysis. Scatter Graph of microarray experi-
mental data shown that the majority genes expression in
SV VSMCs consistent with ITA VSMCs and differen-
tially expressed genes accounted for a small part.
(Figure 5) In SV VSMCs as compared with ITA, 1,075
genes were up-regulated including 406 gene higher than
two-fold; 1,399 genes were down-regulated including
424 lower than two-fold. Differential gene expression
profile was analyzed using Gene Functional Classifi-
cation and exhibited that 27 gene clusters were up-
regulated while 17 gene clusters were down-regulated in
SV VSMCs and 6 representative gene clusters of both
category were selected and shown (Figure 6). Differen-
tially expressed genes terms covered VSMCs phenotypic
markers, proliferation, extracellular matrix (ECM), apo-
tosis/anti-apoptosis, cell cycle, coagulation, IGF binding
protein and other GO terms and various signal transduc-
tion pathways(PA), such as ECM-receptor interaction,
Figure 1 Morphous of SV VSMCs & ITA VSMCs. a). SV VSMCs emigrated from the tissue explant (10 × 10). b). ITA VSMCs emigrated from the
tissue explant (10 × 10). c). SV VSMCs grew form a typical “hill and valley” pattern (10 × 5). d). ITA VSMCs grew form a typical “hill and valley”
pattern (10 × 5).
Figure 2 Identify SV and ITA VSMCs by immunofluorescence staining (10 × 20). SV VSMCs: a). Control b). DAPI display nucleolusc. c). TRITC
display SMα-actin. d). Merge panel. ITA VSMCs: e). Control. f). DAPI display nucleolusc. g). TRITC display SMα-actin. h). Merge panel.
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Figure 3 Proliferation assay of VSMCs from SV & ITA using MTT Kit. a). growth curve of SV VSMCs: b). growth curve of ITA VSMCs. P-value:
obtained by paired t-test between group PDGF-BB and group DMEM/F12 using SPSS 13.0 (*P < 0.05; ** P < 0.01).
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and activator of transcriptase), cell cycle and fibrinolysis
pathways.
ECM-related genes were differentially expressed in VSMCs
from SV and ITA
14 differential expressed ECM-related genes profile were
shown (Figure 7) and consolidation of microarray data
carried out by FQ RT-PCR were well consistent with
microarray analysis. Among 14 ECM genes, 11 genes
were up-regulated in the SV VSMCs: COL4A4, COL11
A1, FN1, TNC, THBS, FBLN, MMP3, MMP9, TIMP3,Figure 4 Morphology diversity under distint treated factors (Magnific
PDGF-BB. ITA VSMC: d) DMEM/F12 e) 10%FBS f) 10 ng/ml PDGF-BB. a) and
edge increased. Cells line more compactly, and gradually formed a multil-o
of the blood vessel wall. b) and e): Cells grew with typical "hill and valley"
of the cells disappeared, and proliferation were enhanced,form many ultra-WNT5A and SGCD; whereas 3 genes were down-
regulated: COL14A1, ELN and PLAT (Figure 8).
PLAT was down-regulated in SV tissue as compared with
ITA
21 cases of SV and 13 cases of ITA tissue including 12
paired SV and ITA from same patients were selected for
RNA isolation for FQ RT-PCR. The data of unpaired or
paired tissue were analyzed respectively and chorusly
revealed that PLAT was dramatically down-regulated
in SV tissue, while compared with ITA. (P < 0.001 and
P = 0.028) (Figure 9).ation 10 × 10). SV VSMC: a) DMEM/F12 b) 10%FBS c) 10 ng/ml
d): Cells grew with long and thin shape, refractive index of the cell
verlapping, bundles, polarity, similar to the organic assembled VSMCs
pattern, from multil-overlapping and non-cell regions. c) and f): Polarity
overlapping regions.
Figure 5 Scatter graph of microarray analysis of gene expression. Fold change Line from diagonal to two side represent 2,3,10,30 fold
respectively. Yellow color: Low expression in VSMCs both ITA & SV. Red color: High expression in VSMCs both ITA & SV. Blue color: Differential
expression in VSMCs from ITA & SV.
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This study demonstrates that SV VSMCs and ITA
VSMCs have different patterns of gene expression. Glo-
bal gene expression profile of VSMCs from SV and ITA
reveal different gene expression patterns between venous
and arterious grafting conduits for CABG. VSMCs from
SV and ITA in vitro exhibited distinct molecular sub-
types. As reported, compared with the ITA VSMCs, SV
VSMCs were more differentiated, as well as stronger po-
tentiality of proliferation and migration [10].
Differentially expressed ECM-related genes in VSMCs
from SV and ITA may play a significant role in the
process of VSMCs proliferation, migration and resten-
osis after CABG. As the major extracellular matrix com-
ponent of vessel wall and the substrate of MMPs and
other protease, collagen regulated VSMCs proliferation
and migration through cell-matrix interaction as binding
with cell surface receptors and other ECM components,
such as tyrosine kinase receptors, fibronectin and integ-
rin [12]. VSMCs from saphenous vein and coronary ar-
tery had very different expression of collagen both in
basic or pathological state, suggesting that collagen may
not only involved in differentiation but also in prolifera-
tion and migration of VSMCs [13]. In injured vascular
and atherosclerotic lesions, VSMCs synthesized more
collagen and adjusted the microenvironment to faciliate
VSMCs migration [14]. Our study showed that a variety
of collagen were differntially expressed in VSMCs from
SV and ITA, correlated with different characters and dis-
tinct responds to stimuli between them. Various collagen
assign tenacity to tissue toughness and different poly-
merized types have respective function. COL4, as major
component of basal membrane, is one of the main bar-
riers of cell migration. Once they were degradated by
collagenase may lead to decollement of basal membraneand accelerated migration of VSMCs [8,15]. COL11 in-
directly produced a marked effect in the migration of
VSMCs through COL1/2 by changing the hardness of
the matrix. COL14, with aggregating collagen fibers as
main function, is widespread in connective tissue espe-
cially in the higher mechanical tension parts of cambium
but less in mature organizations [16]. In our study,
COL4A4, COL11A1 expression were up-regulated while
COL14A1 down-regulated in SV VSMCs, indicated less
migration of SV VSMCs under physiological conditions
may be related to tenacity of matrix in basal mem-
brane. Additionally, down-regulation of COL14A1 in SV
VSMCs indicated that SV was well differentiated tissue.
Elastin (ELN) around VSMCs in the vessel wall en-
dued organizations flexibility and stabilized the vessel
wall by inhibiting the migration of VSMCs, in other
words, decrease of ELN may promote the migration of
VSMCs [17]. As previous discussion, collagen content
could inhibit VSMCs migration. Accordingly, the ratio
between elastin and collagen labeled feature of vascular
wall and it could be regulated by blood flow, concretely
less ratio between elastin and collagen always accom-
pany with slower flow [18]. The migration of VSMCs
maintain a balance under precise regulation of both elas-
tin and collagen. In SV under physiological conditions,
less ratio between elastin and collagen in the structure
accompanied with slower blood flow. Our experiments
confirmed this view by less ELN, more COL4 and
COL11 in SV. Moreover, VSMCs in SV may be pro-
moted by down-regulation of ELN while inhibited by
up-regulation of collagen, hint that they proned to re-
modeling under definite condition because of the bal-
ance in high level.
FN1, TNC, THBS and FBLN are four ECM proteins
that play a role through integrin receptors in regulation
Figure 6 GO terms cluster of up-regulated and down-regulated genes in SV VSMCs. Fold Enrichment (FE): To measure the magnitude of
enrichment. For example, 10% of analysis genes are kinases versus 1% of genes in human genome (this is population background) are kinases.
Thus, the fold enrichment is tenfold. Fold enrichment 1.5 and above are considered as statistical significance. Negative value means that the GO
term was down-regulated in SV VSMCs. GO Terms: A detailed GO item in the annotation source of DAVID system. Each set of color bars
represents a annotation term group(cluster). Values in brackets was Enrichment Score (ES) of each cluster : To rank overall importance (enrichment)
of annotation term groups. It is the geometric mean of all the enrichment P-values (EASE scores) of each annotation term in the group. To
emphasize that the geometric mean is a relative score instead of an absolute P-value, minus log transformation is applied on the average
P-values. ES > 1.3-fold (equivalent to non-log scale 0.05) was considered as statistical significance, mean that the gene cluster was significantly
enriched in analysis list. P-value (or called EASE score, for individual term members): To examine the significance of gene–term enrichment with a
modified Fisher’s exact test (EASE score). P <0.05 was considered as statistical significance.
Zhu et al. Journal of Cardiothoracic Surgery 2013, 8:155 Page 7 of 11
http://www.cardiothoracicsurgery.org/content/8/1/155of cell survival, proliferation and migration through
downstream PKC, PI3K, RHO and other pathways [17].
Suppression of FN polymerization or blockade its con-
nection with VSMCs could inhibit VSMCs migration
and proliferation [19]. TNC could faciliated reorganiza-
tion of cytoskeleton system accordingly promoted intima
thickening and VSMCs migration from tunica media
after arterial injury [20]. But once it was decomposed by
MMPs may leading to inhibition of VSMCs proliferation
and apoptosis induction [21]. THBS indirectly partici-
pated in the migration of VSMCs as a members of cyto-
kines downstream signaling pathways [22]. In summary,
FN1, TNC and THBS binded with integrin receptor andcarried out cell migration functions through downstream
signal transduction [23]. Conversely, FBLN5 could not
only organize ELN network to stable VSMCs in the ELN-
rich regions, but also combined with extracellular super-
oxide dismutase and facilitated it bind with vascular tissue
to protect the vessel wall [24,25]. In this study, FN1, TNC,
THBS were raised as migration promoter factor while
FBLN was also increased as inhibitor in SV VSMCs, all of
them hold the balance in high level to maintain stability of
VSMCs migration. Consequently SV VSMCs may prone
to migrate as responding to stimulus.
VSMCs migration to the intima along with ECM
remodeling are results of dynamic balance of matrix
Figure 7 14 ECM- related gene expression profile of VSMCs from SV and ITA. Differential Folds: The median ratio of gene expression in
VSMCs from SV and ITA. Negative value mean that the gene was down-regulated in VSMCs from SV as comparing with ITA.
Figure 8 Differential expression of 14 ECM-related Genes of VSMC from SV and ITA (n = 12) (FQ RT-PCR). Differential Folds: The median
ratio of gene expression in VSMCs from SV and ITA. Negative value mean that the gene was down-regulated in VSMCs from SV as comparing
with ITA. (* P < 0.05; ** P < 0.01).
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Figure 9 PLAT was differentially expressed in VSMCs and vessel segment of SV and ITA (FQ RT-PCR). Differential Folds: The median ratio
of gene expression in VSMCs from SV and ITA. Negative value mean that the gene was down-regulated in VSMCs from SV as comparing with ITA.
PLAT i: from 21 SV and 13 ITA segments; PLAT p: from 12 paired SV and ITA segments. (** P < 0.001; * P = 0.028).
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metalloproteinases (MMPs) and their inhibitors [6].
Various MMPs have been found in vascular tissue, such
as MMP3 (stromelysin-1, matrilysin 1), MMP9 (gelati-
nase B), and respectived inhibitors TIMPs [26]. MMP9,
synthesized by VSMCs and macrophages in impaired
area, was upregulated along with MMP3 in vascular re-
stenosis and other pathological processes to promote
VSMCs phenotypic conversion. MMP9 can promote
VSMCs migration to the intima by degrading basal
membrane components including collagen type IV, lam-
inin and elastin [26,27]. Potential growth factors and
cytokines may be activated and released after MMP9
having degraded the extracellular matrix, and may com-
bine with the ECM components to further faciliation of
VSMCs phenotype conversion [28]. MMP9 expression
block though small RNA technology may significantly
reduce VSMCs migration and intimal thickening [29].
TIMP3 transfection could decrease about 84% intimal
thickening in human SV and 58% in pig SV. TIMP3
could not only inhibite migration though decreasing
MMPs, but also lead to apoptosis of VSMCs [29]. MMPs
and their inhibitors within subtile balance played antag-
onistic effect in the process of restenosis. Our experi-
ment displayed that all of MMP3, MMP9 and TIMP3
were increased in SV VSMCs, suggesting that MMPs
and TIMP maintained a high level balance in SV under
physiological conditions, once breaked by pathological
fators may lead to rapid progress of disease.
Secreted glycoprotein WNT was a important signaling
molecules of ECM, combined with the receptors (friz-
zled) to produce a marked effect mainly through thesecond messenger β-Catenin. In rat carotid artery injury
model, β-Catenin was significantly increased 7 days after
arterial injury to inhibit VSMCs apoptosis and promote
their survival through cyclin D1 protein and p21 the cell
cycle [30]. SGCD (sarcoglycan complex D) was one of
the components of DGC complex (dystrophin-glycopro-
tein complex), which mediated connection of cyto-
skeleton F-actin and extracellular matrix component
Laminin to play a role in mechanotransduction mecha-
nisms, also mediated signal transduction [31]. It is not
very clear that the detailed effect SGCD and DGC in mi-
gration of VSMCs, but it can be supposed they associ-
ated with cell migration because of their structure
specificity . Upregulated of WNT signaling and SGCD
along with increased ECM-receptor interaction as a re-
sult of 14 differentially expressed ECM-related genes in
SV VSMCs implied that SV VSMCs may be prone to
ECM remodeling as compared to ITA VSMCs.
In SV VSMCs as compared with ITA, 3 folds main
balance in high level correlated with VSMCs migration
are as the following: (1) COL4A4 and COL11A1 were
higher where as ELN lower. Up-regulation of collagen
could inhibit the migration of VSMCs but the reduction
of ELN could promote the migration of VSMCs. (2)
FN1, TNC and THBS along with FBLN were higher.
The former three adhesion molecules could cooperate to
promote cell migration whereas FBLN could inhibite mi-
gration and stabilize the vessel wall. (3) Not only MMP3,
MMP9 but also TIMP3 were higher. MMP3, MMP9
could promote cell migration, whereas their specific in-
hibitor TIMP3 was also increased to antagonize them.
Various ECM-related genes promoting and inhibiting
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ance in higher level in SV VSMCs as compare with ITA,
once the balance was broken by etiological factors may
lead to rapid pathogenic progress, including restenosis
after CABG.
Tissue-type plasminogen activator (PLAT/t-PA), mainly
produced in endothelial cells, can activate plasminogen to
degrade fibrin consequently be an important part of fi-
brinolytic system in the blood. However, it was more
dependent on VSMCs when endothelial layer injury had
occured [9]. PLAT played an important role in coronary
heart disease through its effective anticoagulation, and
according to statistics restonosis occured in 14.4% vein
grafts detected by coronary angiography immediately after
off-pump CABG. Construction of PLAT transfection
model could effectively prevent early stage restonosis after
CABG operation [32]. It was already found that PLAT was
lower in human SV than ITA, and PLAT protein was
lower in supernatant of SV VSMCs cultures. In our study,
PLAT was lower both in SV VSMCs and tunica media
tissue, consistent with the findings of Payeli SK [9]. There-
fore, SV may be prone to generate thrombosis and
neointimal formation, which caused restenosis after
CABG, whereas ITA had potential antithrombotic ability
thereby maintained revascularization.
Conclusions
VSMCs from SV and ITA have distinct gene expression
profile. Both promoting and inhibiting migration ECM-
related genes were higher in VSMCs from SV as com-
pare with ITA suggesting that VSMCs from SV have
more potential migrating capability. Less PLAT expres-
sion both in SV VSMCs and vascular tissue implied that
SV may be prone to generate thrombosis and neointimal
formation, which caused restenosis after CABG, whereas
ITA had potential antithrombotic ability thereby main-
tained revascularization.
Accordingly, ITA should be kept being strongly recom-
mended to be grafted to anterior descending coronary
artery or dominant coronary vessel in CABG for higher
patentcy. Furthermore, appropriate gene therapy, including
PLAT transfection, probably reduce SV grafts restenosis
and benefit patients more after CABG in the future.
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